Chemoinformaics analysis of D-Matrine-N-Oxide
| Molecular Weight | 264.369 | nRot | 0 |
| Heavy Atom Molecular Weight | 240.177 | nRig | 21 |
| Exact Molecular Weight | 264.184 | nRing | 4 |
| Solubility: LogS | -0.07 | nHRing | 4 |
| Solubility: LogP | 0.604 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 44.857 |
| nHD | 0 | BPOL | 28.663 |
| QED | 0.495 |
| Synth | 4.636 |
| Natural Product Likeliness | 1.628 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.997 |
| HIA | 0.984 |
| CACO-2 | -5.518 |
| MDCK | 0.0000192 |
| BBB | 0.13 |
| PPB | 0.0720073 |
| VDSS | 1.046 |
| FU | 0.840231 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.179 |
| CYP2c19-inh | 0.043 |
| CYP2c19-sub | 0.3 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.18 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.279 |
| CYP3a4-inh | 0.034 |
| CYP3a4-sub | 0.604 |
| CL | 13.198 |
| T12 | 0.912 |
| hERG | 0.009 |
| Ames | 0.036 |
| ROA | 0.623 |
| SkinSen | 0.147 |
| Carcinogencity | 0.758 |
| EI | 0.021 |
| Respiratory | 0.213 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.727534 |